CT Scanner Market is expected to reach US$ 10.17 Billion by 2031

Global CT Scanner Market Forecast to 2031: Key Insights

According to our latest study on "Global CT Scanner Market – Global and Regional Share, Trend, and Growth Opportunity Analysis – by Type, Architecture, Technology, Application, End User, and Geography," the market was valued at US$ 6.94 billion in 2024 and is projected to reach US$ 10.17 billion by 2031; it is expected to register a CAGR of 5.7% during 2025–2031. The CT scanner market size represents an expanding niche within the worldwide medical imaging sector. The main factors that stimulate this market are the need for modern diagnostic equipment, the market trends toward an older population, and the progressive frequency of chronic diseases such as cancer and cardiovascular disorders. Besides this, the market has an important opportunity for a solid increase over time, driven by continuous technological progress, including AI applications, low-dose radiation equipment, and faster scanning abilities.

Europe is a mature market with steady growth for CT scanners, driven by the modernization of healthcare, policy-driven procurement, and demographic shifts. Leading CT purchasing markets, such as Germany, France, the UK, and the Nordic countries, focus on replacing older systems with newer generation CT systems that offer better image quality, faster scanning speeds, and lower radiation doses. Environmental sustainability and regulatory compliance have now assumed central importance in procurement considerations, with the implementation of the EU MDR, which requires stricter compliance with the quality and safety standards.

CT Scanner Market

In Central and Eastern Europe, market growth is sustained by EU funding along with equivalent national investments in upgrading healthcare infrastructure and furthering access to advanced diagnostics. With the heavy burden of chronic illnesses, foremost being cancers and cardiovascular next to an aging population, demand for high-performance CT imaging in hospitals and in outpatient clinics remains relevant. Technological advancements such as dual-energy CT, photon-counting detectors, and AI-enabled automation are increasing. Thus, such factors enable Europe to hold a significant CT Scanner market share.

Increasing Burden of Chronic Diseases to Drive Global CT Scanner Market Growth

The global rise is heavily influencing the CT scanner market in chronic and noncommunicable diseases. Among them are cardiovascular disease, cancer, stroke, and neurological disorders, which are becoming more and more common as a result of the aging of the population, the sedentary lifestyle, urbanization, and bad dietary habits. These diseases are at a stage where advanced diagnostic imaging is necessities for early detection, exact localization, and therapy planning, CT (Computed Tomography) is a big part in these functions. Compared to most other imaging techniques, CT scans provide high, resolution, cross, cross-sectional images in a short time and without any harm to the patient, which is why they are an integral part of emergency, outpatient, and inpatient diagnostic workflows.

For instance, in cancer, the use of CT is significant for tumor staging as well as continuing the doctor’s treatments. In cardiology, it helps in areas such as calcium scoring, angiography, and assessment of coronary artery disease. The result is a very high demand for diagnostic services from both developed and emerging countries, particularly among patients who undergo the aging process, which in turn raises the overall utilization of diagnostic modalities such as CT. It has been observed that the number of healthcare systems in which scanning takes place is increasing, particularly in the U.S., Europe, China, and India. The result of this epidemiological shift requires hospitals, diagnostic laboratories, and outpatient imaging centers to purchase more CT devices, and these are most likely to be those with advanced functions to match their continuously evolving clinical needs.

Global CT Scanner Market: Segmental Overview

By type, the market is bifurcated into stationary CT scanners and portable CT scanners. The stationary CT scanners segment held the largest CT scanner market share in 2024. Stationary computed tomography scanners are the basis of diagnostic imaging in hospitals and top medical centers. They provide high, speed, high, resolution imaging for a wide variety of clinical applications, such as cancer, brain diseases, heart diseases, and traumatic injuries. The radiology departments typically house these permanently installed machines, designed for large numbers of patients, which can perform complex imaging protocols with improved accuracy, repeatability, and image quality.

Global CT Scanner Market Analysis: Competitive Landscape and Key Developments

The global CT scanner market report emphasizes the key factors driving the market and the prominent players' developments. GE HealthCare Technologies Inc, Siemens Healthineers AG, Hitachi High-Tech Corp, Medtronic Plc, Koninklijke Philips NV, Neusoft Medical Systems, PLANMED OY, Accuray Incorporated, Canon Medical Systems Corp, and Shanghai United Imaging Healthcare Co., LTD are among the prominent players profiled in the global CT Scanner market report. Market players focus on new product launches, expansion, diversification, and acquisition strategies, which enable them to capitalize on prevailing business opportunities.

• In September 2025, GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Revolution Vibe CT system, which the company said is specifically designed for the rapidly growing coronary computed tomography angiography (CCTA) market. The company also announced its first commercial installation.
• In May 2025, Siemens Healthineers announced the first mobile stroke unit (MSU) featuring the Somatom On.site head computed tomography (CT) scanner in the United States. The technology has been deployed at UCLA Health of Southern California. The MSU is a specialized ambulance designed to quickly deliver advanced stroke care directly to patients to improve their chances of recovery. At the core of UCLA’s MSU is the Somatom On.site, which is integrated into the ambulance to streamline workflow, enhance diagnostic accuracy, and empower MSU teams to deliver timely, life-saving care.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com